GLP-1 Drugs Are Now Being Tested Alongside Chemotherapy in Cancer Patients

Cancer Patients Swapping Chemotherapy for Ivermectin as Oncologists Sound Alarm

A JAMA Network Open study tracking 68 million patient records found ivermectin prescriptions among cancer patients more than doubled after Mel Gibson's Joe Rogan interview. The American Society of Clinical Oncology says there is no clinical evidence the antiparasitic drug treats cancer and that its interactions with chemotherapy remain incompletely understood.

Mayo Clinic researchers find new hope for toughest myeloma through off-the-shelf immunotherapy

A new Mayo Clinic study published in the New England Journal of Medicine has uncovered that an off-the-shelf, dual-antibody therapy can generate deep and durable responses in extramedullary multiple myeloma — one of the most aggressive and treatment-resistant forms of the disease. “We are seeing powerful responses in a disease that historically has resisted every therapy,” [] The post Mayo Clinic researchers find new hope for toughest myeloma through off-the-shelf immunotherapy appeared first on Middle East News 247.

Antibody-Drug Conjugates: Not Quite Worked Out Yet

Antibody-Drug Conjugates: Not Quite Worked Out Yet

Celltrion secures FDA’s 1st interchangeable status for Rituximab biosimilar

Celltrion secures FDA’s 1st interchangeable status for Rituximab biosimilar

Cancer Support Network Foundation donates GHC100,000 to Accra Regional Hospital

The Cancer Support Network Foundation, an NGO championing cancer awareness across Africa, on Thursday presented a GHC100,000 cheque and assorted consumables to the Paediatric Oncology Unit of the Greater Accra Regional Hospital, popularly known as Ridge Hospital.

Iran Develops Cancer Treatment With No Foreign Equivalent

Oncopore G2121 uses precisely controlled electric pulses to dramatically increase chemotherapy absorption by cancer cells, while minimizing damage to healthy tissue.

Citizens reiterates Prime Medicine stock rating on gene therapy focus

Citizens reiterates Prime Medicine stock rating on gene therapy focus

The Race to Build the Next Generation of Weight Loss Pills Is Heating Up

Multiple drug companies are developing GLP-1-based drugs that can be easily taken orally.

Trouble Getting Weight Loss Drugs Covered by Insurance? Here’s What To Know

If your doctor prescribes a GLP-1 medication for weight loss but your insurance won’t cover it, you have options.

Irish researchers find AI can help determine if breast cancer patients need chemotherapy

The study shows that some patients may not benefit from chemotherapy, which can have debilitating effects.

Are GLP-1s Performance-Enhancing Drugs?

Are GLP-1s Performance-Enhancing Drugs? (First column, 8th story, link) Drudge Report Feed needs your support! Become a Patron

University of Calgary developing new immunotherapy cancer treatment

The immunotherapy offers an alternative treatment when chemotherapy, radiation and surgery are no longer effective. The next phase of the trial is recruiting patients.

Medication abortion: Decisions from federal courts, the FDA or Trump’s Department of Justice could try to end access via telehealth

Roughly two-thirds of Americans end their pregnancies by taking two abortion medications – misoprostol and mifepristone. Because these safe, effective medications can be prescribed via telehealth, without an in-office visit, they are how most ...

FDA-approved drug may finally help immunotherapy defeat rare liver cancer

Researchers found that a rare liver cancer evades immunotherapy by luring immune T cells away from the tumor and trapping them in nearby fibrous tissue. An FDA-approved drug called AMD3100 freed those T cells to attack the cancer, significantly improving the effectiveness of immunotherapy in tumor samples.

Medicare patients can get GLP-1s as of July 1

Medicare beneficiaries for the first time will be eligible for coverage of breakthrough GLP-1 weight-loss medications after years of struggling to get the drugs to more seniors. Starting July 1, eligible patients can get GLP-1s to treat obesity for just 50 per month as part of a test program for Medicare, the social safety net []

Medicare Launches GLP-1 Bridge Program Covering Novo Nordisk (CPH: NOVO-B) And Eli Lilly (NYSE: LLY) Weight-Loss Drugs

Medicare is launching a temporary bridge program that will cover select GLP-1 weight-loss medications from two of the pharmaceutical industry’s largest players. The program will extend coverage to Novo Nordisk’s (CPH: NOVO-B) Wegovy, both in injection and tablet form, marking a significant shift in how the federal health program approaches obesity treatment. Eli Lilly’s (NYSE: [] The post Medicare Launches GLP-1 Bridge Program Covering Novo Nordisk (CPH: NOVO-B) And Eli Lilly (NYSE: LLY) Weight-Loss Drugs appeared first on Foreign Policy Journal.

The First Year Of GLP-1 Use Comes With This Hard-To-Detect Side Effect

Experts are raising concerns about a lesser-known GLP-1 side effect.

One Sigmoidoscopy Can Protect You from Colon Cancer for Over 20 Years, New Study Finds

A 23-year trial found one sigmoidoscopy reduced colon cancer risk by 28 and death by 37 in men. Here's what this means for people who haven't been screened.

Nuvation Bio Stock Is Up 190% Despite Recent Pressure. Should Investors Care About This $753,000 Insider Sale?

This oncology biotech advancing targeted therapies reported a notable insider sale amid ongoing clinical-stage development.

Zydus ties up with Apollo Hospitals to expand access to multi-cancer blood test in India

The blood test can screen for 10 common cancers, including bladder, colorectal, breast, prostate, oesophageal, gastric, liver, lung, ovarian and pancreatic cancers

Sunday Science: Killing Cancer Requires Immune Cells To Infiltrate Tumors’ Hostile Microenvironment – Sugar Shields Can Help Them Break In

Sunday Science: Killing Cancer Requires Immune Cells To Infiltrate Tumors’ Hostile Microenvironment – Sugar Shields Can Help Them Break In Ira Mon, 06/22/2026 - 03:25

Weight loss drugs don't work for everyone—here’s why

Some people who take GLP-1 drugs such as semaglutide and tirzepatide see little to no changes to their weight. The reason why may be genetics

A blood test that screens for multiple types of cancer? It could be a reality soon

The FDA is on the cusp of approving the first multi-cancer detection test, which could revolutionize the way health experts screen for cancers, ultimately dramatically improving survival rates.

Pfizer's Lung Cancer Drug Trial Fails To Boost Survival

Pfizer's experimental drug sigvotatug vedotin failed to improve survival in advanced non-small cell lung cancer patients compared to standard therapy, Pfizer announced.

Apollo Cancer Centres Introduces Innovative Multi-Cancer Test

A new blood-based test for multiple cancers has been launched in India by Apollo Cancer Centres in partnership with Zydus Lifesciences and Guardant Health.

Medicare (temporarily) covers GLP-1s starting tomorrow

Click in for more news from The Hill {beacon} Healthcare Health Care The Big Story Temporary Medicare GLP-1 coverage begins tomorrow The Trump administration’s temporary program to cover GLP-1 medications for obesity starts tomorrow and runs through 2027, but we still don’t know for sure how much it will cost taxpayers. © Adobe Stock Medicare is prohibited by law from covering weight-loss drugs but the...

New prostate cancer test detects more dangerous tumours than standard PSA screening, study finds

New prostate cancer test detects more dangerous tumours than standard PSA screening, study finds

David Protein CEO says ‘diet trends are over’ because of GLP-1s: ‘What’s next is really hard to predict’

About 10 of the U.S. population has used GLP-1 drugs, helping to create a projected 82 billion market this year.

Curcumin May Help Lower Blood Sugar in Type 2 Diabetes, Study Finds

Curcumin, the active compound found in turmeric, may improve blood sugar control and reduce chronic inflammation in people with type 2 diabetes, according to a scientific review published in Frontiers in Nutrition. Researchers analyzed clinical trials and meta-analyses evaluating several standardized forms of curcumin to assess its potential role in diabetes management. Curcumin Improves Key Diabetes Markers The review found that appropriately formulated and correctly dosed curcumin may lower fasting blood glucose, reduce glycated hemoglobin (HbA1c) levels and improve insulin sensitivity.

WEGOVY THE WONDER DRUG

Lose weight, reduce the risk of CV disease – unless you are taking Wegovy? [A tale of mystery and intrigue unfolds]. A lot of people have asked me about the weight loss drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 agonists) e.g. Wegovy (semaglutide), or Mounjaro (tirzepatide). What do I think of them, are they []

Tumors found to rewire immune cells, may lead to new cancer treatments

Reprogrammed macrophages activated genes that promote the formation of blood vessels within tumors.

Open letter urges Robert Abela to end reliance on charity funding for cancer treatment

An open letter to Prime Minister Robert Abela says Multiple Myeloma patients are being directed to charitable funding for essential treatment, calling for faster inclusion of EU-approved cancer medicines in the national formulary

FDA scientists flag concerns with peptides, the trendy molecules RFK Jr. supports

Documents reviewing the research on peptides note lack of good evidence of efficacy or safety. Yet an FDA panel will consider easing access to them later this month.